Skip to main content
Log in

Low-dose versus high-dose colistin: cost saving, less toxicity

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2016 Saudi Arabian Riyals

Reference

  • Cara AKS, et al. Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia in Saudi Arabia. International Journal of Clinical Pharmacy : 16 Aug 2018. Available from: URL: http://doi.org/10.1007/s11096-018-0713-x

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Low-dose versus high-dose colistin: cost saving, less toxicity. PharmacoEcon Outcomes News 811, 18 (2018). https://doi.org/10.1007/s40274-018-5247-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5247-x

Navigation